Who’s Hired? BIO’s Duncan Joins AAM

As Coherus Names New Chair Of Scientific Advisory Board

02 Aug 2021

• By Akriti Seth

The Association for Accessible Medicines has appointed former Biotechnology Innovation Organization representative Joanne Duncan as its new chief operating officer. Meanwhile, Coherus has names the new chair of its scientific advisory board, while women’s health specialist Theramex has added to its board of directors.

Appointments — Coherus, Theramax, JB Chemicals and Taro make changes at the leadership level • Source: Alamy

The Association for Accessible Medicines has named former Biotechnology Innovation Organization representative Joanne Duncan as its new chief operating officer, to lead and manage the “implementation of a more comprehensive member recruitment strategy.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Roche Suggests Perjeta Biosimilars May Not Hit Until 2027 ‘Or Later’

29 Apr 2025

• By Dean Rudge

Amid several insights into its expectations of biosimilar competition in 2025, Roche has confirmed the total amount it anticipates being shaved from its top line this year.

Glenmark’s UK Dapagliflozin Blocked On Appeal After Teva Readied Launch

29 Apr 2025

• By Dean Rudge

Glenmark’s advantage for its UK generic version of AstraZeneca’s Forxiga (dapagliflozin) has quickly been snuffed out, after the originator won on appeal its request for injunctive relief.

Hikma Doubles Down On 2025 Guidance Despite Tariff Anxiety And Injectables Competition

28 Apr 2025

• By Adam Zamecnik

Despite industry-wide uncertainty surrounding the Trump administration’s interest in pharma-focused tariffs, Hikma has maintained its guidance for the 2025 financial year.